Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation

Cell Reports

Volumn 8, Issue 3, 2014, Pages 831-842

  Huang, Yunpeng ^a   Wu, Zhihao ^a,b   Cao, Yu ^a   Lang, Minglin ^a   Lu, Bingwei ^b   Zhou, Bing ^a  

^a TSINGHUA UNIVERSITY   (China)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HISTIDINE; TAU PROTEIN; ZINC; ZINC BINDING PROTEIN; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DROSOPHILA; IN VITRO STUDY; MASS SPECTROMETRY; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAUOPATHY; WASTE; ANIMAL; GENETICS; HUMAN; METABOLISM; MUTATION; PHOSPHORYLATION; PROTEINOSIS;

ANIMALS; CYSTEINE; DROSOPHILA; HISTIDINE; HUMANS; MUTATION; PHOSPHORYLATION; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; TAU PROTEINS; TAUOPATHIES; ZINC;

EID: 84923060369     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.047     Document Type: Article

References (54)

1. Adlard, P.A., Cherny, R.A., Finkelstein, D.I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J.P., Perez, K., et al. (2008). Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43-55.
2. Alonso, A.C., Grundke-Iqbal, I., and Iqbal, K. (1996). Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783-787.
3. Alonso, Adel.C., Mederlyova, A., Novak, M., Grundke-Iqbal, I., and Iqbal, K. (2004). Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J. Biol. Chem. 279, 34873-34881.
4. An, W.L., Bjorkdahl, C., Liu, R., Cowburn, R.F., Winblad, B., and Pei, J.J. (2005). Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3β in SH-SY5Y neuroblastoma cells. J. Neurochem. 92, 1104-1115.
5. Atwood, C.S., Scarpa, R.C., Huang, X., Moir, R.D., Jones, W.D., Fairlie, D.P., Tanzi, R.E., and Bush, A.I. (2000). Characterization of copper interactions with alzheimer amyloid β peptides: identification of an attomolar-affinity copper binding site on amyloid β1-42. J. Neurochem. 75, 1219-1233.
6. 2+ in humantau transfected cells. Biochim. Biophys. Acta 1793, 1058-1067.
7. Brunden, K.R., Trojanowski, J.Q., and Lee, V.M.-Y. (2009). Advances in taufocused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 8, 783-793.
8. Budimir, A. (2011). Metal ions, Alzheimer's disease and chelation therapy. Acta Pharm. 61, 1-14.
9. Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., and Hof, P.R. (2000). Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130.
10. Bush, A.I. (2003). The metallobiology of Alzheimer's disease. Trends Neurosci. 26, 207-214.
11. Chatterjee, S., Sang, T.-K., Lawless, G.M., and Jackson, G.R. (2009). Dissociation of tau toxicity and phosphorylation: role of GSK-3β, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet. 18, 164-177.
12. Cherny, R.A., Atwood, C.S., Xilinas, M.E., Gray, D.N., Jones, W.D., McLean, C.A., Barnham, K.J., Volitakis, I., Fraser, F.W., Kim, Y., et al. (2001). Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
13. Dias-Santagata, D., Fulga, T.A., Duttaroy, A., and Feany, M.B. (2007). Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 117, 236-245.
14. Duce, J.A., and Bush, A.I. (2010). Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog. Neurobiol. 92, 1-18.
15. Egaña, J.T., Zambrano, C., Nuñez, M.T., Gonzalez-Billault, C., and Maccioni, R.B. (2003). Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures. Biometals 16, 215-223.
16. Faux, N.G., Ritchie, C.W., Gunn, A., Rembach, A., Tsatsanis, A., Bedo, J., Harrison, J., Lannfelt, L., Blennow, K., Zetterberg, H., et al. (2010). PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J. Alzheimers Dis. 20, 509-516.
17. Good, P.F., Perl, D.P., Bierer, L.M., and Schmeidler, J. (1992). Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 286-292.
18. Greenough, M.A., Camakaris, J., and Bush, A.I. (2013). Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem. Int. 62, 540-555.
19. Hernández, F., and Avila, J. (2007). Tauopathies. Cell. Mol. Life Sci. 64, 2219-2233.
20. Iqbal, K., Alonso Adel, C., Chen, S., Chohan, M.O., El-Akkad, E., Gong, C.X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005). Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 1739, 198-210.
21. Khurana, V., Elson-Schwab, I., Fulga, T.A., Sharp, K.A., Loewen, C.A., Mulkearns, E., Tyynelä, J., Scherzer, C.R., and Feany, M.B. (2010). Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 6, e1001026.
22. Kim, I., Park, E.J., Seo, J., Ko, S.J., Lee, J., and Kim, C.H. (2011). Zinc stimulates tau S214 phosphorylation by the activation of Raf/mitogen-activated protein kinase-kinase/extracellular signal-regulated kinase pathway. Neuroreport 22, 839-844.
23. Kuret, J., Congdon, E.E., Li, G., Yin, H., Yu, X., and Zhong, Q. (2005). Evaluating triggers and enhancers of tau fibrillization. Microsc. Res. Tech. 67, 141-155.
24. Lang, M., Wang, L., Fan, Q., Xiao, G., Wang, X., Zhong, Y., and Zhou, B. (2012). Genetic inhibition of solute-linked carrier 39 family transporter 1 ameliorates Ab pathology in a Drosophila model of Alzheimer's disease. PLoS Genet. 8, e1002683.
25. Lannfelt, L., Blennow, K., Zetterberg, H., Batsman, S., Ames, D., Harrison, J., Masters, C.L., Targum, S., Bush, A.I., Murdoch, R., et al.; PBT2-201-EURO study group (2008). Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, doubleblind, randomised, placebo-controlled trial. Lancet Neurol. 7, 779-786.
26. Li, C., Wang, J., and Zhou, B. (2010). The metal chelating and chaperoning effects of clioquinol: insights from yeast studies. J. Alzheimers Dis. 21, 1249-1262.
27. Lovell, M.A., Robertson, J.D., Teesdale, W.J., Campbell, J.L., and Markesbery, W.R. (1998). Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
28. Ma, Q.F., Li, Y.M., Du, J.T., Kanazawa, K., Nemoto, T., Nakanishi, H., and Zhao, Y.F. (2005). Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR. Biopolymers 79, 74-85.
29. Ma, Q., Li, Y., Du, J., Liu, H., Kanazawa, K., Nemoto, T., Nakanishi, H., and Zhao, Y. (2006). Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Peptides 27, 841-849.
30. Mazanetz, M.P., and Fischer, P.M. (2007). Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat. Rev. Drug Discov. 6, 464-479.
31. Mo, Z.-Y., Zhu, Y.-Z., Zhu, H.-L., Fan, J.-B., Chen, J., and Liang, Y. (2009). Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322. J. Biol. Chem. 284, 34648-34657.
32. Mocchegiani, E., Bertoni-Freddari, C., Marcellini, F., and Malavolta, M. (2005). Brain, aging and neurodegeneration: role of zinc ion availability. Prog. Neurobiol. 75, 367-390.
33. Necula, M., and Kuret, J. (2004). Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J. Biol. Chem. 279, 49694-49703.
34. Nelson, N. (1999). Metal ion transporters and homeostasis. EMBO J. 18, 4361-4371.
35. Nishimura, I., Yang, Y., and Lu, B. (2004). PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116, 671-682.
36. Reed, L.A., Grabowski, T.J., Schmidt, M.L., Morris, J.C., Goate, A., Solodkin, A., Van Hoesen, G.W., Schelper, R.L., Talbot, C.J., Wragg, M.A., and Trojanowski, J.Q. (1997). Autosomal dominant dementia with widespread neurofibrillary tangles. Ann. Neurol. 42, 564-572.
37. Religa, D., Strozyk, D., Cherny, R.A., Volitakis, I., Haroutunian, V., Winblad, B., Naslund, J., and Bush, A.I. (2006). Elevated cortical zinc in Alzheimer disease. Neurology 67, 69-75.
38. Ritchie, C.W., Bush, A.I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003). Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 60, 1685-1691.
39. Saito, Y., Geyer, A., Sasaki, R., Kuzuhara, S., Nanba, E., Miyasaka, T., Suzuki, K., and Murayama, S. (2002). Early-onset, rapidly progressive familial tauopathy with R406W mutation. Neurology 58, 811-813.
40. Schweers, O., Mandelkow, E.-M., Biernat, J., and Mandelkow, E. (1995). Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Natl. Acad. Sci. USA 92, 8463-8467.
41. Solomons, N.W. (1986). Competitive interaction of iron and zinc in the diet: consequences for human nutrition. J. Nutr. 116, 927-935.
42. Suh, S.W., Jensen, K.B., Jensen, M.S., Silva, D.S., Kesslak, P.J., Danscher, G., and Frederickson, C.J. (2000). Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 852, 274-278.
43. Sun, X.Y., Wei, Y.P., Xiong, Y., Wang, X.C., Xie, A.J., Wang, X.L., Yang, Y., Wang, Q., Lu, Y.M., and Wang, J.Z. (2012). Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A). J. Biol. Chem. 287, 11174-11182.
44. Tang, X., and Zhou, B. (2013). Ferritin is the key to dietary iron absorption and tissue iron detoxification in Drosophila melanogaster. FASEB J. 27, 288-298.
45. van Swieten, J.C., Stevens, M., Rosso, S.M., Rizzu, P., Joosse, M., de Koning, I., Kamphorst, W., Ravid, R., Spillantini, M.G., Niermeijer, M., and Heutink, P. (1999). Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann. Neurol. 46, 617-626.
46. Venter, P.A., Dirksen, A., Thomas, D., Manchester, M., Dawson, P.E., and Schneemann, A. (2011). Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies. Biomacromolecules 12, 2293-2301.
47. von Bergen, M., Barghorn, S., Biernat, J., Mandelkow, E.-M., and Mandelkow, E. (2005). Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim. Biophys. Acta 1739, 158-166.
48. Wang, X., Wu, Y., and Zhou, B. (2009). Dietary zinc absorption is mediated by ZnT1 in Drosophila melanogaster. FASEB J. 23, 2650-2661.
49. Wang, L., Kang, J.H., Kim, K.H., and Lee, E.K. (2010). Expression of inteintagged fusion protein and its applications in downstream processing. J. Chem. Technol. Biotechnol. 85, 11-18.
50. Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M., and Feany, M.B. (2001). Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293, 711-714.
51. Xiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., and Wang, J.Z. (2013). Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation. Neurobiol. Aging 34, 745-756.
52. Yamamoto, A., Shin, R.W., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., and Kitamoto, T. (2002). Iron (III) induces aggregation of hyperphosphorylated t and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J. Neurochem. 82, 1137-1147.
53. Yen, S.H., Liu, W.-K., Hall, F.L., Yan, S.-D., Stern, D., and Dickson, D.W. (1995). Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiol. Aging 16, 381-387.
54. Zundel, C.J., Capener, D.C., and McCleary, W.R. (1998). Analysis of the conserved acidic residues in the regulatory domain of PhoB. FEBS Lett. 441, 242-246.